For example, miR-145 has been found to inhibit cancer cell growth, invasion, and metastasis by suppressing EGFR and NUDT1 in lung adenocarcinoma, FSCN-1 in esophageal squamous cell carcinoma, N-cadherin in gastric carcinoma, and IGF in hepatocellular carcinoma [38–41]. This evidence concerns the gene CDH2 and esophageal squamous cell carcinoma.